The present invention provides compounds of formula (I) and pharmaceutically acceptable salts thereof. The formula I compounds inhibit tyrosine kinase enzymes thereby making them useful as anti-cancer agents. The formula I compounds are also useful for the treatment of other diseases which can be treated by inhibiting tyrosine kinase enzymes.
申请公布号
YU84603(A)
申请公布日期
2006.03.03
申请号
YU2003P000846
申请日期
2002.03.26
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
WITTMAN, MARK;BALASUBRAMANIAN, NEELAKANTAN;VELAPARTHI, UPENDER;ZIMMERMANN, KURT;SAULNIER, MARK G.;LIU, PEIYING;SANG, XIAOPENG;FRENNESSON, DAVID;STOFFAN, KAREN;TARRANT, JAMES
